Advertisement
Screener

CHAMPIONS ONCOLOGY, INC. (CSBR) EBITDA

CHAMPIONS ONCOLOGY, INC. (CSBR) EBITDA

  • 2026-07-31: Basis Reported; EBITDA -$95.00K*; Operating income -$409.00K; Depreciation and amortization $314.00K.
  • 2026-04-30: Basis Reported; EBITDA -$222,000.00; Operating income (m); Depreciation and amortization (m).
  • 2026-01-31: Basis Reported; EBITDA $65,000.00; Operating income (m); Depreciation and amortization (m).
  • 2025-10-31: Basis Reported; EBITDA $542,000.00; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2014-04-30 to 2026-04-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-07-31Reported-$95.00K*-$409.00K$314.00K$15.23M-0.62%*$55.00K-$492.00K$7.53M$2.34M(m)$11.00K
2026-04-30Reported-$222,000.00(m)(m)(m)-1.60%(m)(m)(m)(m)(m)(m)
2026-01-31Reported$65,000.00(m)(m)(m)0.39%$37.00K*-$1.34M*$8.83M$2.27M(m)$42.00K
2025-10-31Reported$542,000.00(m)(m)(m)3.60%$242.00K*-$1.74M*$7.26M$2.62M(m)$18.00K
2025-07-31Reported-$169,000.00(m)(m)(m)-1.21%$46.00K$600.00K$8.00M$2.08M(m)$14.00K
2025-04-30Reported-$1.61M(m)(m)(m)-13.01%(m)(m)(m)(m)(m)(m)
2025-01-31Reported$4.9M(m)(m)(m)28.74%$42.00K*$490.00K*$6.62M$1.72M(m)$23.00K
2024-10-31Reported$1.13M(m)(m)(m)8.38%$94.00K*-$283.00K*$7.43M$1.69M(m)$11.00K
2024-07-31Reported$1.78M(m)(m)(m)12.64%$0.00$311.00K$7.07M$1.45M(m)$21.00K
2024-04-30Reported$229,000.00(m)(m)(m)1.64%(m)(m)(m)(m)(m)(m)
2024-01-31Reported-$2.1M(m)(m)(m)-17.44%$92.00K*-$919.00K*$7.85M$2.19M(m)$11.00K
2023-10-31Reported-$1.47M(m)(m)(m)-12.71%$79.00K*$589.00K*$6.62M$2.52M(m)$11.00K
2023-07-31Reported-$2.11M(m)(m)(m)-16.77%$668.00K-$3.99M$7.68M$2.79M(m)$28.00K
2023-04-30Reported-$2.12M(m)(m)(m)-16.23%(m)(m)(m)(m)(m)(m)
2023-01-31Reported-$1.88M(m)(m)(m)-14.74%$754.00K*$1.57M*$7.70M$3.20M(m)$17.00K
2022-10-31Reported$567,000.00(m)(m)(m)3.97%$604.00K*$3.29M*$7.44M$2.60M(m)$14.00K
2022-07-31Reported$244,000.00(m)(m)(m)1.78%$754.00K-$195.00K$7.05M$2.89M(m)$17.00K
2022-04-30Reported$89,000.00(m)(m)(m)0.69%(m)(m)(m)(m)(m)(m)
2022-01-31Reported$1.23M(m)(m)(m)9.29%$405.00K*$4.26M*$6.41M$2.18M(m)$11.00K
2021-10-31Reported$609,000.00(m)(m)(m)5.17%$566.00K*$1.23M*$5.61M$2.30M(m)$12.00K
2021-07-31Reported$142,000.00(m)(m)(m)1.26%$907.00K$216.00K$5.40M$2.30M(m)$14.00K
2021-04-30Reported-$480,000.00(m)(m)(m)-4.54%(m)(m)(m)(m)(m)(m)
2021-01-31Reported$1.26M(m)(m)(m)11.66%$1.20M*$135.00K*$4.62M$1.88M(m)$15.00K
2020-10-31Reported$261,000.00(m)(m)(m)2.58%$506.00K*$879.00K*$5.64M$1.65M(m)$15.00K
2020-07-31Reported$248,000.00(m)(m)(m)2.60%$718.00K-$715.00K$5.34M$1.60M(m)$13.00K
2020-04-30Reported-$1.7M(m)(m)(m)-19.39%(m)(m)(m)(m)(m)(m)
2020-01-31Reported$617,000.00(m)(m)(m)6.85%$171.00K*$279.00K*$4.33M$1.39M(m)$12.00K
2019-10-31Reported(m)$291.00K(m)$7.63M(m)-$227.00K*$360.00K$3.88M$1.34M(m)$11.00K
2019-07-31Reported(m)-$614.00K(m)$6.74M(m)$749.00K-$279.00K$3.75M$1.30M(m)$15.00K
2019-01-31Reported(m)-$370.00K(m)$6.43M(m)$207.00K*$1.21M*$3.43M$1.27M(m)$0.00
2018-10-31Reported(m)$275.00K(m)(m)(m)$275.00K*$64.00K*$3.45M$1.19M(m)$1.00K
2018-07-31Reported(m)$481.00K(m)(m)(m)$211.00K$336.00K$3.08M$1.09M(m)$0.00
2018-01-31Reported(m)-$67.00K(m)(m)(m)$75.00K*$445.00K*$2.47M$1.04M(m)$2.00K
2017-10-31Reported(m)-$70.00K(m)(m)(m)$32.00K*$268.00K*$2.65M$1.11M(m)$11.00K
2017-07-31Reported(m)-$619.00K(m)(m)(m)$910.00K-$1.95M$2.64M$1.12M(m)$4.00K
2017-01-31Reported(m)-$1.40M(m)(m)(m)$151.00K*-$684.00K(m)$998.00K(m)$0.00
2016-10-31Reported(m)-$493.00K(m)(m)(m)$13.00K*$116.00K(m)$1.01M(m)-$5.00K
2016-07-31Reported(m)-$2.52M(m)(m)(m)$17.00K-$2.44M(m)$1.21M(m)$14.00K
2016-01-31Reported(m)-$2.37M(m)(m)(m)$132.00K*-$726.00K*(m)$999.00K(m)$31.00K
2015-10-31Reported(m)-$2.49M(m)(m)(m)$15.00K*-$2.58M*(m)$919.00K(m)$41.00K
2015-07-31Reported(m)-$2.90M(m)(m)(m)$29.00K-$2.54M(m)$1.10M(m)$6.00K
2015-01-31Reported(m)-$3.42M(m)(m)(m)$13.00K*(m)(m)$1.09M(m)$12.00K
2014-10-31Reported(m)-$3.67M(m)(m)(m)$38.00K*(m)(m)$1.25M(m)$10.00K
2014-07-31Reported(m)-$3.73M(m)(m)(m)$33.00K(m)(m)$1.42M(m)$5.00K
2014-01-31Reported(m)-$1.41M(m)(m)(m)$88.00K*(m)(m)$535.00K(m)$5.00K
2013-10-31Reported(m)-$1.70M(m)(m)(m)$36.00K*$242.00K*(m)$677.00K(m)$3.00K
2013-07-31Reported(m)-$766.00K(m)(m)(m)$40.00K-$2.14M(m)$402.00K(m)$3.00K
2013-01-31Reported(m)-$720.00K(m)(m)(m)$7.00K*-$578.00K*(m)$592.00K(m)$5.00K
2012-10-31Reported(m)-$1.92M(m)(m)(m)$9.00K*-$748.00K*(m)$436.00K(m)$1.00K
2012-07-31Reported(m)-$1.60M(m)(m)(m)$19.00K-$1.81M(m)$387.00K(m)$3.00K
2012-01-31Reported(m)-$1.77M(m)(m)(m)$211.00K*-$413.00K*(m)$930.00K(m)$0.00
2011-10-31Reported(m)-$2.47M(m)(m)(m)$65.00K*-$1.76M*(m)$1.01M(m)$0.00
2011-07-31Reported(m)-$2.21M(m)(m)(m)$95.00K-$1.53M(m)$541.00K(m)$0.00
2011-01-31Reported(m)-$786.00K(m)(m)(m)$22.00K*$1.69M*(m)$434.00K(m)$0.00
2010-10-31Reported(m)-$1.01M(m)(m)(m)$5.00K*-$750.00K*(m)$673.00K(m)$0.00
2010-07-31Reported(m)-$603.00K(m)(m)(m)$20.00K-$436.00K(m)$919.00K(m)$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-04-30Reported$260,000.00(m)(m)(m)0.44%$564.00K-$4.47M$30.90M$9.08M(m)$246.00K
2025-04-30Reported$6.15M(m)(m)(m)10.81%$389.00K$7.39M$28.39M$6.83M(m)-$75.00K
2024-04-30Reported-$5.46M(m)(m)(m)-10.88%$836.00K-$6.14M$29.40M$9.54M(m)-$32.00K
2023-04-30Reported-$3.16M(m)(m)(m)-5.86%$2.87M$3.97M$29.53M$11.54M(m)$68.00K
2022-04-30Reported$2.11M(m)(m)(m)4.29%$2.38M$6.50M$23.63M$9.37M(m)$35.00K
2021-04-30Reported$1.29M(m)(m)(m)3.15%$3.28M-$1.68M$21.45M$7.20M(m)$75.00K
2020-04-30Reported-$1.1M(m)(m)(m)-3.41%$2.22M$2.90M$17.00M$5.85M(m)$130.00K
2019-04-30Reported$876,000.00(m)(m)(m)3.24%$834.00K$1.86M(m)$4.80M(m)$103.00K
2018-04-30Reported-$994,000.00(m)(m)(m)-4.91%$1.23M-$1.23M(m)$4.40M(m)$33.00K
2017-04-30Reported-$6.64M(m)(m)(m)(m)$766.00K-$2.84M(m)$4.29M(m)$19.00K
2016-04-30Reported-$10.16M(m)(m)(m)(m)$322.00K-$6.41M(m)$4.19M(m)$92.00K
2015-04-30Reported-$13.02M(m)(m)(m)(m)$119.00K-$9.63M(m)$4.84M(m)$127.00K
2014-04-30Reported-$6.05M(m)(m)(m)(m)$234.00K(m)(m)$2.27M(m)$17.00K
2013-04-30Reported(m)-$6.22M(m)(m)(m)$57.00K-$4.29M(m)$1.92M(m)$10.00K
2012-04-30Reported(m)-$9.06M(m)(m)(m)$519.00K-$5.23M(m)$2.94M(m)-$2.00K
2011-04-30Reported(m)-$5.24M(m)(m)(m)$85.00K-$54.00K(m)$2.91M(m)$11.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioStem Technologies, Inc. (BSEM)United States$0.069B
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Vaxart, Inc. (VXRT)United States$0.080B3.84
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48